ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

WGS vs TDOC // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

GeneDx Holdings Corp. (Class A) (NASDAQ) VS. Teladoc Health Inc. (NYSE) • 15-METRIC TALLY: WGS 7 — TDOC 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WGS VS. TDOC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC WGS TDOC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 69.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -4.10% -17.00% +12.90 WGS /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 0.67% 18.00% -17.33 TDOC /fcf-yield <GO>
Operating Margin -3.10% -10.40% +7.30 WGS /operating-margins <GO>
Net Profit Margin -4.90% -7.90% +3.00 WGS /net-margins <GO>
Revenue Growth (YoY) 40.00% -1.50% +41.50 WGS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.32 0.45 +2.87 WGS /balance-sheet <GO>
Piotroski F-Score Quality 8/9 7/9 +1.00 WGS /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.5 74.1 -25.60 TDOC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 32.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.06B $1.55B $508.2M WGS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR WGS REV TDOC REV WGS GROSS % TDOC GROSS % WGS FCF TDOC FCF
FY 2025 $427.5M $2.53B 69.7% — $14.3M $285.5M
FY 2024 $305.4M $2.57B 63.6% — -$34.0M $282.9M
FY 2023 $202.6M $2.60B — — -$180.1M $232.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WGS // BETA —
TDOC // BETA 1.08